Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Boxthorn Berry (Lycium ferocissimum) contains high concentrations of zeaxanthin and beta-carotene that accumulate in retinal tissues, providing specific protection for macular health. Its immunomodulatory polysaccharides activate macrophages and enhance natural killer cell activity through complement system stimulation.
Reported Benefits (Provisional)
Origin & History
Boxthorn Berry (Lycium ferocissimum) is a resilient fruit native to the arid plains, coastal scrublands, and semi-desert zones of Australia, with related species found in Asia and Southern Africa. Particularly abundant in South Australia and New South Wales, this berry is rich in carotenoids and polysaccharides. It is valued for its traditional use in supporting vision, immunity, and overall vitality.
Research Narrative (Provisional)
Emerging research, including in vitro and animal studies, supports the Boxthorn Berry's potential for antioxidant defense, vision enhancement, and immune modulation, largely attributed to its carotenoid and polysaccharide content. Studies indicate its role in mitigating oxidative stress and supporting cellular health. Further human clinical trials are warranted to confirm these effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Minerals: Zinc, Selenium - Phytochemicals/Bioactives: Carotenoids (Zeaxanthin, Beta-carotene), Flavonoids, Polysaccharides - Macronutrients: Essential amino acids
Reported Mechanism (Provisional)
Zeaxanthin and lutein from boxthorn berry selectively accumulate in the macular pigment, filtering blue light and neutralizing reactive oxygen species in photoreceptor cells. The berry's Lycium barbarum polysaccharides (LBPs) bind to complement receptor 3 on immune cells, triggering cytokine release and enhancing phagocytic activity. Betaine compounds support hepatic methylation pathways, facilitating phase II detoxification enzyme expression.
Clinical Narrative (Provisional)
Current evidence consists primarily of in vitro studies and small animal trials with sample sizes typically under 50 subjects. Laboratory studies demonstrate antioxidant capacity measured at 4,310 ORAC units per 100g and zeaxanthin content of 2.4mg per ounce of dried berries. Animal studies show 15-30% improvements in retinal function markers, but human clinical trials are limited to preliminary observational studies. The evidence base requires substantial expansion through randomized controlled trials to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.